<bill session="119" type="h" number="1627" updated="2025-10-25T08:05:44Z">
  <state datetime="2025-02-26">REFERRED</state>
  <status>
    <introduced datetime="2025-02-26"/>
  </status>
  <introduced datetime="2025-02-26"/>
  <titles>
    <title type="display">TREATS Act</title>
    <title type="short" as="introduced">Telehealth Response for E-prescribing Addiction Therapy Services Act</title>
    <title type="short" as="introduced">TREATS Act</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="N000188"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2025-03-04"/>
    <cosponsor bioguide_id="B001318" joined="2025-09-15"/>
    <cosponsor bioguide_id="B001300" joined="2025-03-04"/>
    <cosponsor bioguide_id="C001068" joined="2025-03-04"/>
    <cosponsor bioguide_id="C001078" joined="2025-03-04"/>
    <cosponsor bioguide_id="C001119" joined="2025-10-24"/>
    <cosponsor bioguide_id="D000230" joined="2025-03-04"/>
    <cosponsor bioguide_id="D000530" joined="2025-03-04"/>
    <cosponsor bioguide_id="D000624" joined="2025-03-04"/>
    <cosponsor bioguide_id="F000466" joined="2025-02-26"/>
    <cosponsor bioguide_id="H001090" joined="2025-03-04"/>
    <cosponsor bioguide_id="H001085" joined="2025-03-04"/>
    <cosponsor bioguide_id="J000309" joined="2025-03-04"/>
    <cosponsor bioguide_id="J000288" joined="2025-03-04"/>
    <cosponsor bioguide_id="K000375" joined="2025-03-04"/>
    <cosponsor bioguide_id="K000399" joined="2025-09-10"/>
    <cosponsor bioguide_id="L000599" joined="2025-03-04"/>
    <cosponsor bioguide_id="L000607" joined="2025-10-08"/>
    <cosponsor bioguide_id="M001205" joined="2025-03-04"/>
    <cosponsor bioguide_id="M001196" joined="2025-03-04"/>
    <cosponsor bioguide_id="O000019" joined="2025-03-04"/>
    <cosponsor bioguide_id="P000620" joined="2025-03-04"/>
    <cosponsor bioguide_id="S001205" joined="2025-03-04"/>
    <cosponsor bioguide_id="T000478" joined="2025-03-04"/>
    <cosponsor bioguide_id="T000467" joined="2025-04-29"/>
    <cosponsor bioguide_id="T000487" joined="2025-03-04"/>
    <cosponsor bioguide_id="T000469" joined="2025-03-04"/>
    <cosponsor bioguide_id="T000482" joined="2025-03-04"/>
    <cosponsor bioguide_id="W000797" joined="2025-03-04"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-26" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2025-02-26">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referred To"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Mental health"/>
  </subjects>
  <amendments/>
  <summary date="2025-08-26T16:24:24Z" status="Introduced in House">Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act

This bill permanently allows health care practitioners to prescribe certain controlled substances for treating substance use disorders via telehealth without evaluating the patient in person.

Generally, a health care practitioner may not prescribe a controlled substance via telehealth unless they first conduct an in-person medical evaluation. Federal regulations currently provide a temporary exception to this requirement, allowing practitioners to prescribe schedule II-V controlled substances for legitimate medical purposes (such as treating substance use disorders)&#160;via telehealth without an in-person evaluation. However, this temporary regulatory flexibility expires on December 31, 2025.

The bill permanently allows practitioners to prescribe schedule III-V controlled substances for the treatment of a substance use disorder via telehealth without conducting an in-person evaluation. In such instances, a practitioner may conduct a telehealth evaluation using audio-only or audio and video equipment. &#160;</summary>
</bill>
